{"legislative_session": "2026", "identifier": "HB2148", "title": "Controlled dangerous substances; terms; pain management clinics; Oklahoma Bureau of Narcotics and Dangerous Drugs Control; exemptions; registration procedures; compliance; suspension; licensed prescriber; designated administrator; operations requirements; infection control; data collection; reporting; written policy; investigation by Bureau; penalties; rules; effective date.", "from_organization": "~{\"classification\": \"lower\"}", "classification": ["bill"], "subject": [], "abstracts": [], "other_titles": [], "other_identifiers": [], "actions": [{"description": "First Reading", "date": "2025-02-03", "organization_id": "~{\"classification\": \"lower\"}", "classification": ["introduction", "reading-1"], "related_entities": []}, {"description": "Authored by Representative Kannady", "date": "2025-02-03", "organization_id": "~{\"classification\": \"lower\"}", "classification": [], "related_entities": []}, {"description": "Second Reading referred to Rules", "date": "2025-02-04", "organization_id": "~{\"classification\": \"lower\"}", "classification": ["reading-2", "referral-committee"], "related_entities": []}], "sponsorships": [{"name": "Kannady", "classification": "primary", "entity_type": "person", "primary": true, "person_id": "~{\"name\": \"Kannady\"}", "organization_id": null}], "related_bills": [], "versions": [{"note": "Introduced", "links": [{"url": "https://www.oklegislature.gov/cf_pdf/2025-26 INT/hB/HB2148 INT.PDF", "media_type": "application/pdf"}], "date": "", "classification": ""}], "documents": [], "citations": [], "sources": [{"url": "http://www.oklegislature.gov/BillInfo.aspx?Bill=HB2148&session=2600", "note": ""}], "extras": {}, "jurisdiction": {"id": "ocd-jurisdiction/country:us/state:ok/government", "name": "Oklahoma", "classification": "state", "division_id": "ocd-division/country:us/state:ok"}, "scraped_at": "2026-02-01T08:36:49+00:00", "_id": "26a3a7b2-ff49-11f0-9e27-decce19b135c"}